Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer revision/version was updated to **v3.5.3**. This reflects a metadata/version update rather than a substantive change to the trial information.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded Melanoma as a topic tag and included related topics via MedlinePlus Genetics. Updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check17 days agoChange DetectedRemoved the Melanoma related topic from the related topics section and deleted the MedlinePlus Genetics related topic (including the related topics header).SummaryDifference0.2%

- Check24 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as a related topic.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision: v3.5.0 added. Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.3 were removed.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.